Other/unspecified enthesopathies of lower limb, excluding foot

M13_ENTESOPATHYLOWNAS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M76.8, M76.9 Hospital discharge: ICD-9 — 7267B\|7266F\|7266X\|7267X Cause of death: ICD-10 — M76.8, M76.9 Cause of death: ICD-9 — 7267B\|7266F\|7266X\|7267X 2 out of 7 registries used, show all original rules.	3039
4. Check minimum number of events None	3039
5. Include endpoints None	3039
6. Filter based on genotype QC (FinnGen only)	3039

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	M13_ENTESOPATHYLOWNAS
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M76[8-9]
HD_ICD_9	7267B\|7266F\|7266X\|7267X
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M76[8-9]
COD_ICD_9	7267B\|7266F\|7266X\|7267X
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other/unspecified enthesopathies of lower limb, excluding foot based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	19066	11159	7830
Only index persons	18272	10791	7481
Unadjusted period prevalence (%)
Whole population	0.28	0.32	0.22
Only index persons	0.35	0.40	0.29
Median age at first event (years)
Whole population	45.48	49.99	39.01
Only index persons	45.16	49.69	38.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3039	2039	1000
Unadjusted period prevalence (%)	0.61	0.70	0.44
Median age at first event (years)	50.68	51.09	49.84

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2719: Matched controls
27190

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

41.1

323.0

497

147

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

338.1

323.0

1044

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

590.3

323.0

1652

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

29.9

315.0

431

170

NGM10

NOMESCO Finland

Fasciotomy of of knee or lower leg

86.8

308.5

343

M48.0

ICD-10 Finland

Spinal stenosis

50.1

259.4

315

N03AX16

ATC

pregabalin; oral

5.5

241.9

851

2089

N03AX12

ATC

gabapentin; oral

7.7

241.4

617

994

M79.6

ICD-10 Finland

Pain in limb

4.1

241.3

1356

5332

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

32.3

236.3

316

110

M54.5

ICD-10 Finland

Low back pain

4.3

220.4

1050

3477

M54.4

ICD-10 Finland

Lumbago with sciatica

7.3

219.9

586

992

N02AX02

ATC

tramadol; systemic, rectal

3.8

219.6

1339

5513

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

97.2

195.5

215

M01AH05

ATC

etoricoxib; oral

3.3

183.6

1894

11088

M25.5

ICD-10 Finland

Pain in joint

3.6

180.4

1090

4267

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.1

166.2

1456

7366

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

6.9

144.6

387

634

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

16.1

139.0

232

157

M54.9

ICD-10 Finland

Dorsalgia, unspecified

7.3

138.1

357

555

M03BX02

ATC

tizanidine; oral

2.8

134.7

1852

11791

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

9.4

132.4

288

339

N02AJ06

ATC

codeine and paracetamol; systemic

2.9

132.4

1162

5611

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

156.5

127.5

134

M70.6

ICD-10 Finland

Trochanteric bursitis

4.7

126.3

474

1157

M01AB05

ATC

diclofenac; systemic, rectal

2.7

119.1

1950

13233

M03BC01

ATC

orphenadrine (citrate); systemic

3.0

107.7

766

3137

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

25.1

106.7

152

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

226.9

106.4

109

N02BE01

ATC

paracetamol; systemic, rectal

3.0

101.0

2361

18601

L03

ICPC

Low back symptom/complaint

3.0

99.0

690

2762

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

24.8

97.3

139

N06AX21

ATC

duloxetine; oral

4.4

97.0

384

973

M54.3

ICD-10 Finland

Sciatica

11.0

95.9

189

183

A02BC05

ATC

esomeprazole; systemic

2.4

93.0

1175

6581

M01AE02

ATC

naproxen; oral, rectal

2.3

92.7

1631

10733

M01AC06

ATC

meloxicam; systemic, rectal

2.4

92.6

1064

5675

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

92.3

1043

5513

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

14.6

92.3

159

115

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.8

90.8

694

2928

M02AA07

ATC

piroxicam; topical

2.4

87.8

1061

5766

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

864.9

86.1

M47.82

ICD-10 Finland

Other spondylosis, cervical region

22.3

84.3

124

A02BC02

ATC

pantoprazole; systemic

2.2

84.1

1745

12132

M54.1

ICD-10 Finland

Radiculopathy

17.8

82.4

131

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

9.8

79.2

166

180

M76.6

ICD-10 Finland

Achilles tendinitis

7.6

78.3

192

270

M76.0

ICD-10 Finland

Gluteal tendinitis

17.4

76.2

122

M43.1

ICD-10 Finland

Spondylolisthesis

36.2

75.9

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

71.1

759

3785

N06AA09

ATC

amitriptyline; systemic

4.1

70.2

296

785

M79.1

ICD-10 Finland

Myalgia

3.1

69.8

431

1550

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.5

68.8

671

3184

M01AH01

ATC

celecoxib; oral (coxibs)

2.8

68.4

507

2055

L13

ICPC

Hip symptom/complaint

3.0

67.6

445

1670

R51.80

ICD-10 Finland

Headache

2.9

67.3

460

1768

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

674.4

67.3

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.4

67.2

368

1211

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

67.0

752

3825

X59

ICD-10 Finland

Exposure to unspecified factor

2.6

66.0

567

2503

M47.9

ICD-10 Finland

Spondylosis, unspecified

29.6

65.8

M54.6

ICD-10 Finland

Pain in thoracic spine

5.3

63.0

204

412

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

62.7

H02AB06

ATC

prednisolone; systemic

2.0

62.6

1219

7830

M03BC51

ATC

orphenadrine, combinations; systemic

2.2

62.6

798

4285

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.6

62.4

305

916

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.6

62.1

541

2396

S18

ICPC

Laceration/cut

2.0

61.9

1090

6720

L17

ICPC

Foot/toe symptom/complaint

2.3

61.0

692

3512

M54.2

ICD-10 Finland

Cervicalgia

4.9

60.2

208

451

M01AX17

ATC

nimesulide; oral

2.4

60.0

635

3111

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.5

58.5

301

940

M01AE03

ATC

ketoprofen; systemic, rectal

2.0

58.1

977

5873

R03AC02

ATC

salbutamol; inhalant

1.9

57.2

1411

9787

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

56.6

672

3465

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

9.6

56.3

118

128

R52.2

ICD-10 Finland

Other chronic pain

7.3

55.7

139

200

J01AA02

ATC

doxycycline; systemic

2.0

55.1

2067

16612

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.4

54.7

291

931

J01FA10

ATC

azithromycin; systemic

1.9

54.5

1641

12136

J01DB01

ATC

cefalexin; oral

2.1

53.7

2193

18113

L86

ICPC

Back syndrome with radiating pain

6.0

52.8

152

266

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.7

52.4

392

1578

R4110

NOMESCO Finland

Physiotherapy

2.1

51.8

718

3944

M50.3

ICD-10 Finland

Other cervical disc degeneration

26.4

51.8

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

50.8

1021

6482

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

17.5

50.4

A02BC01

ATC

omeprazole; systemic

2.1

50.4

699

3833

A02BC03

ATC

lansoprazole; oral

2.1

49.7

724

4048

L16

ICPC

Ankle symptom/complaint

2.9

49.5

329

1226

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.5

49.5

450

2014

M01AH02

ATC

rofecoxib; oral

2.8

48.7

340

1308

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

249.3

48.2

M79.7

ICD-10 Finland

Fibromyalgia

6.4

48.0

131

214

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

47.9

1211

8282

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.5

47.8

416

1816

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

32.2

47.8

L15

ICPC

Knee symptom/complaint

2.2

47.6

561

2851

ZXA05

NOMESCO Finland

Left side

2.1

47.3

653

3559

X58

ICD-10 Finland

Exposure to other specified factors

2.5

47.1

421

1865

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

47.1

732

4185

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

5.4

46.9

148

289

R5599

NOMESCO Finland

Other rehabilitation service

7.7

46.9

112

151

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.8

46.7

121

184

R52.9

ICD-10 Finland

Pain, unspecified

3.2

46.1

258

852

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

239.0

46.1

ZXA00

NOMESCO Finland

Right side

2.0

46.0

684

3835

NE1AA

NOMESCO Finland

Pelvis X-ray examination

4.1

45.7

189

488

L08

ICPC

Shoulder symptom/complaint

2.3

44.9

487

2376

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

10.0

44.6

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

43.1

44.5

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

3.8

44.4

200

557

M01AE01

ATC

ibuprofen; systemic, rectal

2.3

44.1

2443

21570

M77.4

ICD-10 Finland

Metatarsalgia

3.6

43.2

206

602

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

3.0

43.0

271

972

N06AX11

ATC

mirtazapine; oral

1.9

42.9

801

4880

R06.0

ICD-10 Finland

Dyspnoea

2.1

42.4

578

3111

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.6

42.3

329

1345

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.7

42.2

315

1253

R01AD09

ATC

mometasone; nasal

1.8

42.2

1222

8611

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

16.6

42.2

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.7

42.1

319

1283

M01AX05

ATC

glucosamine; oral

2.3

42.0

457

2224

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

3.4

41.4

213

661

WX320

NOMESCO Finland

Spinalanesthesy

2.0

41.2

591

3247

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

40.9

450

2199

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

40.9

598

3311

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

4.3

40.7

159

389

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

3.0

40.5

248

872

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

403.3

40.2

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

208.0

39.9

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

109.2

39.8

N02AA05

ATC

oxycodone; systemic

2.7

39.6

306

1241

N06AX16

ATC

venlafaxine; oral

2.3

39.5

393

1828

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.6

39.5

324

1360

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

39.4

598

3353

M54.8

ICD-10 Finland

Other dorsalgia

5.7

39.1

116

211

G44.2

ICD-10 Finland

Tension-type headache

2.4

39.0

352

1557

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

38.8

532

2857

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

38.8

1006

6791

J02AC01

ATC

fluconazole; systemic

1.7

38.6

1124

7857

SPAT1153

SPAT

Removal of sutures

1.9

38.6

770

4768

J01DA01

ATC

[U] cefalexin; systemic

1.7

38.3

1617

12598

UJF32

NOMESCO Finland

Coloscopy

2.0

38.3

596

3367

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

3.2

38.1

218

730

B01AB05

ATC

enoxaparin; parenteral

1.9

37.9

745

4584

J01CA04

ATC

amoxicillin; systemic

1.8

37.6

2143

18231

NF1AA

NOMESCO Finland

Hip X-ray examination

3.3

37.6

199

630

WX110

NOMESCO Finland

Local anesthesy

1.7

37.2

1797

14490

L29

ICPC

Musculoskeletal sympt/complt other

3.1

37.1

221

759

J01FA06

ATC

roxithromycin; oral

1.7

36.8

1035

7130

L14

ICPC

Leg/thigh symptom/complaint

3.1

36.4

211

711

L28

ICPC

Limited function/disability (L)

2.4

36.2

340

1534

A01

ICPC

Pain general/multiple sites

3.1

36.0

207

696

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

44.6

36.0

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.3

35.9

194

623

J01FF01

ATC

clindamycin; systemic

1.9

35.8

679

4112

M77.1

ICD-10 Finland

Lateral epicondylitis

2.9

35.6

233

853

R01AD08

ATC

fluticasone; nasal

1.8

35.6

763

4813

R01BA52

ATC

pseudoephedrine, combinations; oral

1.8

35.6

825

5343

R06AE07

ATC

cetirizine; oral

1.7

35.5

1171

8424

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

35.3

1849

15132

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

35.2

423

2141

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

11.2

35.2

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

35.1

1428

10881

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

34.9

1325

9904

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

20.4

34.8

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

37.2

34.7

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

6.9

34.6

131

M45

ICD-10 Finland

Ankylosing spondylitis

39.7

34.4

R53

ICD-10 Finland

Malaise and fatigue

2.0

33.9

487

2650

R03DC03

ATC

montelukast; oral

2.1

33.8

437

2278

M67.8

ICD-10 Finland

Other specified disorders of synovium and tendon

8.6

33.7

M35.7

ICD-10 Finland

Hypermobility syndrome

11.9

33.6

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.0

33.6

208

735

XA402

NOMESCO Finland

ENMG

7.0

32.9

122

L01

ICPC

Neck symptom/complaint

2.3

32.7

335

1572

M70.7

ICD-10 Finland

Other bursitis of hip

5.8

32.5

170

7266X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of knee[ENTHESOPATHIA GENUS ALIA DEFINITA SEU NUD]

+∞

32.3

A02BA02

ATC

ranitidine; systemic

2.0

32.3

453

2436

R42

ICD-10 Finland

Dizziness and giddiness

2.0

32.3

484

2675

R20.2

ICD-10 Finland

Paraesthesia of skin

3.1

32.1

184

616

AA1AD

NOMESCO Finland

CT of head and brain

2.0

32.1

504

2834

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.1

31.8

386

1956

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.6

31.6

246

1000

N05BA04

ATC

oxazepam; oral

1.8

31.4

615

3740

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

31.3

1253

9388

M02AA10

ATC

ketoprofen; topical

2.1

31.2

397

2052

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.6

31.1

252

1045

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

31.0

650

4038

9211

FHL

Exploration or removal of diskusprolapse

316.3

30.9

J01MA02

ATC

ciprofloxacin; systemic

1.7

30.8

890

6099

M77.9

ICD-10 Finland

Enthesopathy, unspecified

4.4

30.7

115

271

N01

ICPC

Headache

2.4

30.2

278

1233

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.5

29.9

262

1133

M01AB55

ATC

diclofenac, combinations; oral

3.1

29.7

172

580

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

6.9

29.7

111

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

4.0

29.5

123

320

Z50.1

ICD-10 Finland

Other physical therapy

3.4

29.2

146

442

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.5

29.1

143

427

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.8

29.1

195

723

P01AB01

ATC

metronidazole; oral, rectal

1.6

28.9

995

7122

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.7

28.9

206

795

R05

ICPC

Cough

1.8

28.8

547

3281

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

28.7

736

4849

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

29.6

28.5

J01FA09

ATC

clarithromycin; systemic

1.7

28.5

822

5601

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.5

28.4

245

1053

R03BA05

ATC

fluticasone; inhalant

1.9

28.4

468

2669

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.7

28.3

199

760

R06AX27

ATC

desloratadine; oral

1.7

28.3

734

4848

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

9.8

28.2

H02AB07

ATC

prednisone; oral

2.1

27.9

363

1888

M01AH03

ATC

valdecoxib; oral

2.9

27.9

175

622

M54

ICD-10 Finland

Dorsalgia

2.3

27.9

266

1203

S83.2

ICD-10 Finland

Tear of meniscus, current

2.7

27.8

200

775

R07.3

ICD-10 Finland

Other chest pain

2.5

27.8

224

928

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

27.7

989

7122

N05CF01

ATC

zopiclone; oral

1.7

27.6

725

4798

L12

ICPC

Hand/finger symptom/complaint

2.1

27.6

358

1860

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

27.4

308

1502

WX002

NOMESCO Finland

Sedation and analgesia

1.9

27.4

474

2748

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

27.3

726

4822

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

27.2

261

1181

7267X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of ankle and tarsus[ENTHESOPATHIA TARSI ALIA SEU NUD]

+∞

27.1

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.8

27.0

559

3439

H02AB04

ATC

methylprednisolone; systemic

2.0

27.0

364

1920

M23.8

ICD-10 Finland

Other internal derangements of knee

3.7

27.0

120

331

M43.0

ICD-10 Finland

Spondylolysis

62.7

27.0

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

3.5

26.9

132

394

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.3

26.8

102

244

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

6.4

26.7

113

K30

ICD-10 Finland

Functional dyspepsia

2.3

26.6

260

1187

M89.0

ICD-10 Finland

Algoneurodystrophy

14.9

26.5

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

29.5

26.3

N02AC04

ATC

dextropropoxyphene; oral

5.2

26.1

165

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

4.6

26.1

209

N03AE01

ATC

clonazepam; systemic

3.1

25.9

150

506

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

25.9

229

994

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

263.0

25.7

R52.1

ICD-10 Finland

Chronic intractable pain

17.6

25.7

H04.10

ICD-10 Finland

Dry eye syndrome

2.3

25.7

254

1167

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

25.6

248

1126

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.1

25.6

146

488

M01AX01

ATC

nabumetone; oral

3.7

25.5

116

326

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.2

25.2

140

459

SPAT1263

SPAT

Sampling

1.6

25.2

1006

7406

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

+∞

25.0

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

25.0

308

1561

N04BC05

ATC

pramipexole; oral

2.8

24.8

171

646

M01AC01

ATC

piroxicam; systemic, rectal

2.1

24.6

318

1646

SPAT1310

SPAT

Counselling related to known health issue

1.6

24.5

740

5067

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.2

24.5

274

1333

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.4

24.4

222

978

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

24.4

184

734

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

24.2

491

2990

R60.0

ICD-10 Finland

Localized oedema

2.3

24.2

245

1138

N06AB04

ATC

citalopram; systemic

1.8

24.1

521

3235

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

24.1

1646

13649

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.5

24.0

197

822

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.1

24.0

278

1372

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.5

24.0

193

795

K07.60

ICD-10 Finland

Snapping jaw

3.0

24.0

145

505

C07AB07

ATC

bisoprolol; oral

1.6

23.9

951

6967

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.0

23.9

352

1917

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

23.9

317

1659

A07EC01

ATC

sulfasalazine; oral, rectal

2.5

23.8

199

841

A03FA02

ATC

cisapride; oral, rectal

2.6

23.7

182

731

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

23.5

245

1153

UKC02

NOMESCO Finland

Cystoscopy

2.1

23.5

295

1505

R74

ICPC

Upper respiratory infection acute

1.6

23.3

730

5028

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

23.3

935

6855

ZXA10

NOMESCO Finland

Bilateral

1.8

23.2

435

2578

XQ800

NOMESCO Finland

Prick test

2.3

23.2

217

969

M24.2

ICD-10 Finland

Disorder of ligament

6.3

23.2

100

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

23.1

242

1142

J45.1

ICD-10 Finland

Nonallergic asthma

2.6

23.1

171

673

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

23.0

406

2356

T79.6

ICD-10 Finland

Traumatic ischaemia of muscle

14.8

22.9

NFL30

NOMESCO Finland

Transposition of muscle of hip or thigh

8.5

22.8

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

3.5

22.7

108

316

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

22.6

406

2370

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

121.0

22.6

NHL30

NOMESCO Finland

Suture or reinsertion of tendon of foot

8.6

22.6

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.1

22.6

125

410

SPAT1301

SPAT

No procedures

1.6

22.4

711

4909

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.7

22.4

158

607

SPAT1229

SPAT

Assessment of need for aid

2.6

22.2

166

657

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

22.2

1323

10565

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

21.9

335

1847

G47.3

ICD-10 Finland

Sleep apnoea

1.7

21.9

470

2903

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

21.9

G43.9

ICD-10 Finland

Migraine, unspecified

2.7

21.9

158

615

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

2.0

21.8

286

1486

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

4.3

21.8

195

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

21.7

166

666

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

5.1

21.6

139

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

21.5

1445

11800

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

21.5

297

1577

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

21.4

533

3439

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

21.4

510

3252

R01AD12

ATC

fluticasone furoate; nasal

1.6

21.3

750

5302

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

21.3

1073

8238

R05

ICD-10 Finland

Cough

1.8

21.2

432

2622

Z71.8

ICD-10 Finland

Other specified counselling

1.6

21.0

572

3785

M53.2

ICD-10 Finland

Spinal instabilities

60.5

20.9

L02

ICPC

Back symptom/complaint

2.3

20.9

209

963

M13.9

ICD-10 Finland

Arthritis, unspecified

2.4

20.8

182

785

Z01.2

ICD-10 Finland

Dental examination

1.5

20.8

1017

7746

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

5.1

20.8

132

S76.3

ICD-10 Finland

Injury of muscle and tendon of the posterior muscle group at thigh level

6.4

20.8

SPAT1216

SPAT

Assessment of functional ability

2.0

20.7

299

1611

R21

ICPC

Throat symptom/complaint

1.7

20.7

493

3137

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

211.5

20.6

M76.7

ICD-10 Finland

Peroneal tendinitis

12.1

20.5

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

3.8

20.5

242

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

20.3

196

889

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

20.2

231

1133

M77.8

ICD-10 Finland

Other enthesopathies, not elsewhere classified

15.2

20.2

G54.0

ICD-10 Finland

Brachial plexus disorders

5.1

20.2

128

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

20.2

415

2527

F45.8

ICD-10 Finland

Other somatoform disorders

2.3

20.1

192

866

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

20.1

681

4756

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

20.1

448

2794

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.5

20.1

166

694

M22.4

ICD-10 Finland

Chondromalacia patellae

3.3

20.1

102

315

D07AC01

ATC

betamethasone; topical

1.5

20.0

784

5666

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

5.1

20.0

129

M19.8

ICD-10 Finland

Other specified arthrosis

3.6

20.0

257

SPAT1260

SPAT

Consultation of another employee

1.8

20.0

394

2366

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

20.0

150

597

N05BA01

ATC

diazepam; systemic, rectal

1.9

20.0

304

1669

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

19.9

261

1356

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.7

19.9

137

516

H02BX01

ATC

methylprednisolone, combinations; systemic

2.9

19.9

124

439

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

3.1

19.8

109

357

M70.8

ICD-10 Finland

Other soft tissue disorders related to use, overuse and pressure

7.9

19.8

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

19.8

370

2185

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

19.7

388

2329

N06AA10

ATC

nortriptyline; systemic

5.0

19.6

128

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.4

19.6

178

785

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.6

19.6

150

603

NH3BG

NOMESCO Finland

MRI of foot

12.2

19.5

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

19.5

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.4

19.5

179

791

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

19.4

660

4608

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

3.1

19.4

111

372

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

19.4

146

582

WX290

NOMESCO Finland

Other blockade of nerve

1.5

19.4

1105

8651

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

19.3

220

1075

C03CA01

ATC

furosemide; systemic

1.7

19.3

486

3136

L11

ICPC

Wrist symptom/complaint

2.2

19.2

196

915

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

4.6

19.1

145

XF402

NOMESCO Finland

ECG with work load test

2.1

19.1

234

1183

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

22.7

19.0

SPAT1211

SPAT

Application of soft bandage

2.2

19.0

211

1020

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.8

19.0

222

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

19.0

603

4137

P01BA02

ATC

hydroxychloroquine; oral

2.2

19.0

206

984

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

4.0

18.9

198

E0000UV

ATC

1.5

18.9

943

7169

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

18.9

114

396

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

18.9

253

1321

J01MA12

ATC

levofloxacin; systemic

1.7

18.8

393

2398

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

18.8

172

760

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

18.8

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

18.8

A11

ICPC

Chest pain NOS

2.4

18.7

163

700

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.4

18.7

164

710

A04

ICPC

Weakness/tiredness general

1.9

18.7

277

1506

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

3.9

18.6

201

C07AA05

ATC

propranolol; systemic

1.7

18.6

461

2956

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.3

18.6

172

765

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.6

18.6

139

553

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.6

18.5

243

J01EA01

ATC

trimethoprim; systemic

1.6

18.5

568

3862

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

9.6

18.3

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

4.8

18.3

129

J31.0

ICD-10 Finland

Chronic rhinitis

2.2

18.3

194

918

S80.0

ICD-10 Finland

Contusion of knee

2.3

18.2

169

752

R50.9

ICD-10 Finland

Fever, unspecified

1.8

18.2

310

1771

M76.5

ICD-10 Finland

Patellar tendinitis

7.4

18.2

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

18.2

420

2639

SPAT1312

SPAT

General health counselling

1.5

18.2

731

5297

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

18.1

233

1201

N06AB10

ATC

escitalopram; oral

1.6

18.1

487

3199

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

18.0

272

1487

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

3.1

18.0

103

345

N05CF02

ATC

zolpidem; oral

1.7

18.0

417

2622

N02AJ13

ATC

tramadol and paracetamol; systemic

5.8

18.0

L84

ICPC

Back syndrome without radiat pain

3.1

17.9

100

332

G57.6

ICD-10 Finland

Lesion of plantar nerve

4.7

17.8

133

M75.2

ICD-10 Finland

Bicipital tendinitis

4.1

17.8

170

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

17.8

193

922

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

17.8

186

875

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.7

17.8

125

479

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

67.0

17.7

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

17.7

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

3.3

17.7

284

C05AA08

ATC

fluocortolone; rectal, topical

1.8

17.6

331

1951

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.4

17.6

264

C09CA06

ATC

candesartan; oral

1.6

17.6

479

3151

M01AB08

ATC

etodolac; oral

2.2

17.5

175

808

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

181.1

17.5

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

4.5

17.4

141

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.0

17.4

101

344

M77.0

ICD-10 Finland

Medial epicondylitis

3.9

17.4

189

NHA30

NOMESCO Finland

Exploration of joint of ankle or foot, arthroscopic

13.9

17.3

G57.1

ICD-10 Finland

Meralgia paraesthetica

6.8

17.2

1220

FHL

Arthroscopy

3.0

17.2

102

352

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

5.9

17.2

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

17.2

935

7202

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

3.6

17.2

216

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.6

17.1

126

497

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.0

17.1

221

1137

R03BA01

ATC

beclometasone; inhalant

1.8

17.1

318

1868

R06AE09

ATC

levocetirizine; oral

1.7

16.8

368

2272

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

5.0

16.7

107

7267B

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of ankle and tarsus[TENDINITIS TIBIALIS ANTERIORIS ET POSTERIORIS]

+∞

16.7

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.3

16.7

259

R03AC03

ATC

terbutaline; inhalant

1.8

16.6

322

1915

C01CA24

ATC

epinephrine; parenteral

2.3

16.6

158

713

R4120

NOMESCO Finland

Occupational therapy

2.3

16.6

152

672

J01DA06

ATC

[U] cefuroxime; systemic

1.7

16.6

361

2226

R35

ICD-10 Finland

Polyuria

2.6

16.4

125

502

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

20.2

16.4

W19

ICD-10 Finland

Unspecified fall

2.1

16.4

199

1002

A02BC04

ATC

rabeprazole; oral

2.1

16.3

201

1016

D19

ICPC

Teeth/gum symptom/complaint

1.5

16.3

632

4525

KMAK

NOMESCO Finland

1.4

16.3

1286

10596

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

16.3

507

3447

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

16.3

673

4887

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

2.2

16.2

175

834

S89.9

ICD-10 Finland

Unspecified injury of lower leg

3.2

16.2

281

N05AH04

ATC

quetiapine; oral

1.7

16.2

372

2329

G04CA02

ATC

tamsulosin; oral

1.8

16.2

310

1837

D01

ICPC

Abdominal pain/cramps general

1.9

16.2

240

1305

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

16.1

164

762

G04BD08

ATC

solifenacin; oral

2.4

16.1

143

623

R05FB02

ATC

cough suppressants and expectorants

1.4

16.0

864

6620

R00.2

ICD-10 Finland

Palpitations

2.2

16.0

166

778

S29

ICPC

Skin symptom/complaint other

1.7

15.9

360

2245

R03BA02

ATC

budesonide; inhalant

1.7

15.9

403

2593

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

15.9

269

1530

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

15.9

125

513

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

15.8

634

4566

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

15.8

298

1758

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.0

15.8

101

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.9

15.8

225

1203

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

2.7

15.8

109

413

G04BD12

ATC

mirabegron; oral

2.1

15.7

192

968

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.4

15.7

130

547

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

5.4

15.7

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

15.7

189

946

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

15.6

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

15.6

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.4

15.6

132

561

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

6.7

15.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

15.5

250

1401

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.9

15.4

242

1342

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

15.4

305

1828

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

7.7

15.3

R02

ICPC

Shortness of breath/dyspnoea

1.9

15.3

241

1338

A01AB09

ATC

miconazole; local oral

2.0

15.2

199

1030

K02.1

ICD-10 Finland

Caries of dentine

1.4

15.2

1376

11552

M20.2

ICD-10 Finland

Hallux rigidus

3.1

15.2

283

M76.3

ICD-10 Finland

Iliotibial band syndrome

13.1

15.2

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.3

15.1

145

655

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

15.1

204

1069

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.0

15.1

295

M67.4

ICD-10 Finland

Ganglion

2.1

15.1

165

794

D06

ICPC

Abdominal pain localized other

2.1

15.1

185

934

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.9

15.0

326

ACC51

NOMESCO Finland

Release of median nerve

2.1

14.9

166

803

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.4

14.9

125

530

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

14.9

118

484

UJD02

NOMESCO Finland

Gastroscopy

2.6

14.9

108

422

R13

ICD-10 Finland

Dysphagia

2.3

14.9

133

583

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

6.3

14.8

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

14.8

751

5668

K10.3

ICD-10 Finland

Alveolitis of jaws

2.5

14.8

117

479

SPAT1283

SPAT

Restricted health certificate

1.6

14.7

435

2910

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

14.7

524

3669

SPAT1240

SPAT

Therapeutic discussion

1.8

14.7

255

1463

R03AC13

ATC

formoterol; inhalant

2.5

14.6

113

457

M01AE52

ATC

naproxen and esomeprazole; oral

3.0

14.6

284

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.7

14.6

103

397

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

5.0

14.6

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.0

14.6

200

1056

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.3

14.6

136

607

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.0

14.5

185

950

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

5.5

14.5

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.9

14.4

205

1098

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

14.4

279

1659

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

14.4

302

1838

H57.1

ICD-10 Finland

Ocular pain

3.0

14.3

289

C10AA05

ATC

atorvastatin; oral

1.4

14.3

716

5382

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

14.3

594

4297

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.6

14.3

181

WZA90

NOMESCO Finland

Other doctors statement

1.5

14.3

503

3508

NF1DA

NOMESCO Finland

X-ray of hips

4.6

14.2

109

R03BA08

ATC

ciclesonide; inhalant

2.0

14.2

193

1015

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

3.6

14.2

182

B01AA03

ATC

warfarin; systemic

1.7

14.2

318

1975

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

14.1

108

437

M65.3

ICD-10 Finland

Trigger finger

2.5

14.1

107

430

A06AD11

ATC

lactulose; oral

1.8

14.1

238

1354

S82

ICPC

Naevus/mole

1.8

14.1

274

1630

NBE35

NOMESCO Finland

Transposition of ligament of shoulder, arthroscopic

5.6

14.0

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

14.0

348

2225

RF210

NOMESCO Finland

3.2

14.0

232

NHL99

NOMESCO Finland

Other operation on muscle or tendon of ankle or foot

8.9

13.9

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

3.9

13.9

145

L09

ICPC

Arm symptom/complaint

2.6

13.9

105

421

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.7

13.9

160

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.8

13.9

155

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.3

13.8

218

JAH01

NOMESCO Finland

Laparoscopy

2.5

13.8

109

449

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.3

13.8

123

538

M25.2

ICD-10 Finland

Flail joint

4.7

13.8

R06AX22

ATC

ebastine; oral

1.6

13.8

419

2821

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

3.1

13.7

242

N05BA12

ATC

alprazolam; oral

1.8

13.6

229

1301

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

13.6

145

689

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

3.0

13.6

270

G04BD04

ATC

oxybutynin; oral, transdermal

2.5

13.6

110

458

M03BX01

ATC

baclofen; systemic

4.9

13.5

XF404

NOMESCO Finland

Ambulatory ECG

2.0

13.5

176

912

M01AE11

ATC

tiaprofenic acid; oral, rectal

2.8

13.5

307

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.5

13.5

106

435

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

13.4

1125

9250

XKD00

NOMESCO Finland

Uroflowmetry

1.8

13.4

234

1343

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

3.5

13.4

180

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

13.4

312

1955

NFL20

NOMESCO Finland

Freeing of muscle of hip or thigh

18.3

13.4

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

13.3

899

7127

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

13.3

323

2051

TAB20

NOMESCO Finland

Epidural puncture

13.8

13.2

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

3.4

13.2

188

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

13.2

244

1427

M01AC02

ATC

tenoxicam; systemic, rectal

2.4

13.2

110

465

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

5.2

13.2

M24.8

ICD-10 Finland

Other specific joint derangements, not elsewhere classified

7.6

13.1

R51

ICD-10 Finland

Headache

2.3

13.1

119

526

N17

ICPC

Vertigo/dizziness

1.8

13.1

213

1195

T78.4

ICD-10 Finland

Allergy, unspecified

2.4

13.1

107

449

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

13.0

265

1600

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

13.0

186

998

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

13.0

284

J20

ICD-10 Finland

Acute bronchitis

1.9

13.0

199

1094

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

10.1

13.0

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.9

12.9

181

961

L18

ICPC

Muscle pain

2.8

12.9

315

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

7.4

12.9

TAB00

NOMESCO Finland

Lumbar puncture

2.5

12.9

103

426

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

12.9

320

2044

A03CA02

ATC

clidinium and psycholeptics; oral

2.3

12.9

117

517

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

798

3570

2.68

112.39

1.4

1.2

9.0

13.2

u/ml

1.01

293

1439

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

802

3780

2.52

99.90

1.5

1.2

31.3

32.2

iu/ml

0.04

243

1208

(3013707) Erythrocyte sedimentation rate by Westergren method

2291

17143

2.37

90.00

5.1

3.6

10.7

11.4

mm/h

1.75

2167

15869

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1007

5973

2.03

67.16

2.4

2.0

203.8

240.1

u/l

0.36

955

5592

(3037522) Nuclear Ab [Titer] in Serum

620

3080

2.27

65.35

1.5

1.3

376.6

569.1

titre

2.75

135

660

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

858

4849

2.07

65.01

2.0

1.7

0.9

1.1

mg/l

2.68

631

3635

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2245

17654

2.04

63.20

7.8

7.2

75.3

77.8

u/l

2.05

2117

16597

(3013115) Eosinophils [#/volume] in Blood

1655

11907

1.86

59.25

6.7

6.1

0.2

e9/l

0.35

1496

10495

(3006315) Basophils [#/volume] in Blood

1609

11477

1.85

59.20

6.5

5.8

0.0

e9/l

0.73

1431

9937

(3019198) Lymphocytes [#/volume] in Blood

1644

11817

1.85

58.89

6.4

5.8

2.0

1.9

e9/l

0.36

1476

10455

(3037467) Urinalysis macro (dipstick) panel - Urine

2039

15706

1.91

58.40

4.8

3.8

—

(3001604) Monocytes [#/volume] in Blood

1601

11438

1.84

58.24

6.5

5.8

0.6

e9/l

0.00

1428

9907

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1491

10501

1.82

56.05

6.4

6.6

1.2

mmol/l

0.95

1283

8835

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1369

9435

1.82

54.92

5.5

5.9

1.2

mmol/l

0.93

1239

8542

(3013650) Neutrophils [#/volume] in Blood by Automated count

1780

13390

1.79

52.12

8.4

9.5

3.9

4.0

e9/l

1.03

1577

11700

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

352

1502

2.52

51.50

2.5

2.3

23.6

23.9

au/ml

0.01

122

(3022096) Basophils/100 leukocytes in Blood

1471

10511

1.77

50.95

6.7

6.0

0.7

0.21

1376

9820

(3006504) Eosinophils/100 leukocytes in Blood

1506

10867

1.76

50.13

6.7

5.9

2.8

0.00

1408

10141

(3019069) Monocytes/100 leukocytes in Blood

1512

10934

1.76

49.85

6.9

6.2

8.4

0.43

1424

10269

(3031040) Bacteria [#/volume] in Urine by Automated count

1913

14801

1.79

49.84

5.2

3.8

3834.9

1922.2

e6/l

0.40

198

(3002030) Lymphocytes/100 leukocytes in Blood

1549

11321

1.75

48.83

6.7

6.0

29.5

28.5

2.99

1450

10585

(42870588) Differential panel, method unspecified - Blood

1127

7553

1.78

47.81

6.5

5.9

—

(3018010) Neutrophils/100 leukocytes in Blood

1523

11138

1.74

47.37

6.5

5.8

56.1

56.9

2.12

1425

10445

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

321

1366

2.51

47.08

1.4

1.3

44.5

55.3

au/ml

0.33

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2778

24581

2.52

45.83

16.9

11.5

19.3

23.0

mg/l

7.70

2244

18843

(3032080) INR in Blood by Coagulation assay

1182

8142

1.74

44.81

9.0

7.9

1.2

inr

0.06

339

2465

(3013826) Glucose [Moles/volume] in Serum or Plasma

1683

12774

1.71

44.67

4.9

4.4

6.4

6.6

mmol/l

4.11

1593

11830

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1119

7615

1.74

44.13

3.9

3.0

34.6

63.7

ng/l

1.11

664

4595

(3008898) HLA-B27 [Presence]

204

712

3.00

43.88

1.1

1.0

—

(3018418) pH of Serum or Plasma

948

6163

1.78

43.78

3.7

4.0

7.4

0.24

165

1215

(40768797) Stomach Pathology biopsy report

541

2948

2.02

43.18

1.3

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

222

820

2.84

43.07

1.2

0.2

1.0

u/ml

1.36

(36304419) Bacteria [Presence] in Urine

879

5612

1.80

43.03

3.4

2.8

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1093

7443

1.73

42.65

3.6

2.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

993

6614

1.74

41.74

2.8

2.5

60.6

58.7

u/l

0.14

916

6100

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1327

9618

1.67

40.45

2.5

2.2

76.6

nmol/l

0.01

1195

8766

(3030467) Casts [#/volume] in Urine by Automated count

878

5712

1.76

39.72

3.5

2.8

0.3

0.4

e6/l

2.15

686

4194

(3024561) Albumin [Mass/volume] in Serum or Plasma

1285

9286

1.66

39.26

5.0

4.9

36.5

35.8

g/l

4.23

1188

8656

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2271

19062

1.76

38.54

4.6

3.9

14.6

pmol/l

0.63

2099

17463

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1202

8570

1.67

38.47

2.1

1.8

98.9

96.9

pmol/l

0.68

583

4380

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1518

11484

1.64

38.44

5.8

6.3

10.3

11.4

umol/l

5.00

1436

10885

(3026493) Urate [Moles/volume] in Serum or Plasma

859

5617

1.74

37.84

2.4

2126.4

4117.8

umol/l

1.24

731

4986

(3018095) Leukocytes [#/volume] in Urine

1086

7589

1.67

37.26

4.0

3.3

81.8

112.8

e6/l

0.81

794

5144

(3009261) Glucose [Presence] in Urine by Test strip

1482

11206

1.63

37.13

3.9

3.2

0.0

estimate

0.23

284

2017

(3002582) Erythrocytes [#/volume] in Urine

934

6302

1.70

36.43

3.5

2.9

132.3

96.0

e6/l

0.16

736

4748

(3048689) Calprotectin [Mass/mass] in Stool

499

2812

1.93

35.56

2.1

2.4

107.6

125.0

ug/g

0.60

392

2247

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1405

10595

1.61

34.79

4.1

3.8

—

(3035350) Ketones [Presence] in Urine by Test strip

1452

11045

1.60

34.60

3.9

3.1

0.0

estimate

0.80

283

2029

(3021601) Nitrite [Presence] in Urine by Test strip

1459

11116

1.60

34.50

5.3

4.4

0.0

estimate

0.50

290

2079

(3015736) pH of Urine

1165

8452

1.61

33.49

3.6

3.0

—

5.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

564

3387

1.82

32.66

2.9

2.5

1.2

1.3

e6/l

0.18

315

1831

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2569

22698

1.85

32.58

5.6

4.5

1.8

2.2

mu/l

2.36

2403

20937

(3044889) 12 lead EKG panel

1983

16396

1.60

32.03

3.8

3.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2754

24954

2.11

31.67

17.7

13.0

139.7

mmol/l

0.11

2714

24249

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

799

5346

1.67

31.31

1.4

1.3

0.9

1.9

u/ml

5.02

203

1452

(3026782) Osmolality of Urine

634

4023

1.73

30.11

2.9

2.5

527.9

544.3

mosm/kgh2o

1.00

555

3417

(3023103) Potassium [Moles/volume] in Serum or Plasma

2755

25049

2.07

30.07

18.0

13.1

4.0

3.9

mmol/l

0.99

2711

24280

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

610

3838

1.74

29.83

4.5

3.2

341.3

457.0

ng/l

0.36

420

2748

(3007164) IgA [Mass/volume] in Serum or Plasma

717

4720

1.68

29.66

1.5

1.4

2.2

2.3

g/l

1.08

401

2972

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

766

5143

1.65

29.31

2.9

845.3

1338.9

ng/l

4.67

637

4347

(3000850) Epithelial cells [#/volume] in Urine

661

4274

1.70

29.19

2.8

2.4

5.1

6.9

e6/l

3.71

597

3721

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1364

10573

1.53

27.66

3.2

2.7

100.0

113.3

ug/l

1.54

1260

9866

(3036481) Cortisol [Moles/volume] in Serum or Plasma

363

1997

1.93

27.37

2.2

2.1

369.9

378.6

nmol/l

0.36

333

1849

(3044640) Blood type and Crossmatch panel - Blood

977

7063

1.56

27.09

2.4

2.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

519

3221

1.74

26.34

3.1

2.6

4.4

3.0

e6/l

1.29

276

1669

(40758558) Short blood count panel - Blood

835

5876

1.58

25.80

6.1

7.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

164

683

2.48

24.94

1.6

1.9

—

(3033658) Prothrombin time (PT) actual/Normal

807

5672

1.58

24.92

4.6

3.8

92.5

92.8

0.13

795

5544

(3007853) Bacteria identified in Skin by Aerobe culture

414

2459

1.79

24.33

1.9

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2034

17390

1.51

24.25

3.6

3.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

282

1503

1.97

23.21

3.0

4.1

74.8

86.2

ng/l

2.10

246

1310

(3015377) Calcium [Moles/volume] in Serum or Plasma

1002

7477

1.51

23.20

3.0

3.5

2.4

mmol/l

0.40

872

6659

(3021960) Folate [Moles/volume] in Serum or Plasma

672

4605

1.59

22.85

1.7

1.5

19.6

20.9

nmol/l

1.84

590

3952

(3021589) Normoblasts [#/volume] in Blood

1330

10527

1.47

22.84

10.4

8.8

0.0

e9/l

0.42

1097

8583

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

746

5238

1.56

22.82

2.4

2.1

2.9

mg/l

0.18

643

4451

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1995

17086

1.49

22.77

3.5

2.8

46.7

44.2

u/l

0.62

1870

16050

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

359

2110

1.80

21.74

2.8

2.3

29.5

62.8

u/l

0.87

309

1840

(3005322) IgE [Units/volume] in Serum or Plasma

268

1442

1.94

21.42

1.4

1.3

111.7

222.4

u/ml

3.63

254

1336

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

752

5354

1.54

21.40

2.3

2.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2576

23448

1.65

21.12

14.2

10.9

84.7

84.6

ml/min/173m2

0.03

2229

19143

(3023368) Bacteria identified in Blood by Culture

749

5345

1.53

21.03

4.5

4.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2458

22147

1.57

20.78

5.8

5.0

39.1

mmol/mol

0.10

2304

20608

(40761511) CBC panel - Blood by Automated count

2804

26167

1.93

20.68

15.1

10.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2828

26505

1.96

19.99

18.2

13.3

74.5

74.0

umol/l

0.50

2828

26496

(3003327) Ova and parasites identified in Stool by Light microscopy

164

754

2.24

19.93

2.0

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

690

4896

1.53

19.71

1.6

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

131

549

2.45

19.67

1.4

288.1

292.4

ug/g

0.07

307

(3011397) Hemoglobin [Presence] in Urine by Test strip

690

4905

1.53

19.52

3.6

3.1

—

(3026008) Bacteria identified in Urine by Culture

844

6259

1.48

19.44

3.3

2.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

148

660

2.31

19.34

1.5

1.7

0.2

g/l

0.06

141

624

(3022145) Colonoscopy Study observation

394

2469

1.68

18.88

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2838

26702

1.95

18.73

11.8

9.2

26.6

26.3

u/l

0.41

2759

25799

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

151

690

2.25

18.63

1.5

1.7

1.2

g/l

0.73

144

654

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

559

3832

1.56

18.54

2.7

3.0

2.4

mmol/l

1.12

472

3384

(40768804) Tissue Pathology biopsy report

1241

9965

1.41

18.40

2.1

2.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

518

3498

1.58

18.33

1.8

1.7

1173.6

1130.0

nmol/l

0.51

396

2657

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

404

2575

1.66

18.10

2.6

2.8

5.3

8.3

umol/l

6.28

350

2237

(3042936) Bacteria identified in Isolate by Culture

444

2899

1.62

18.07

2.3

2.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

106

420

2.58

17.93

1.6

1.7

4816.0

15009.1

e6/l

3.24

308

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1094

8625

1.42

17.85

4.2

3.2

—

(3000494) Fungus identified in Specimen by Culture

406

2632

1.63

16.95

1.5

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

724

5342

1.47

16.70

4.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

250

1432

1.81

16.38

1.8

1.6

—

(3000492) Spirometry study

373

2387

1.64

16.37

1.5

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

138

643

2.20

16.26

1.2

31.8

45.2

u/ml

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2573

23745

1.55

16.23

4.8

4.0

5.9

5.8

mmol/l

0.75

2393

21831

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

129

591

2.24

15.85

1.2

3.4

8.0

u/ml

0.92

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

995

7858

1.40

15.54

3.6

3.2

29.9

35.1

u/l

1.61

939

7485

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

127

587

2.21

15.28

1.2

5.8

3.4

u/ml

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

460

3144

1.55

15.22

1.9

1.8

—

(3022948) Iron [Moles/volume] in Serum or Plasma

471

3253

1.53

14.83

2.4

13.6

umol/l

0.07

439

3025

(3052851) Hemolysis interference index of Serum or Plasma

129

608

2.17

14.79

2.5

3.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

178

945

1.94

14.77

1.9

2.0

40.4

38.9

u/l

0.45

164

862

(3021788) Differential panel - Synovial fluid

307

2.65

14.49

1.7

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

221

1266

1.80

14.46

1.0

—

(3013512) EKG study

800

6154

1.41

14.36

4.0

3.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

212

1204

1.82

14.27

1.8

2.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

330

2121

1.62

14.16

1.8

1.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

129

619

2.13

14.15

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

249

1490

1.73

14.02

2.2

2.7

66.3

66.6

g/l

0.20

226

1370

(3004789) Transferrin [Mass/volume] in Serum or Plasma

434

2994

1.52

13.67

2.4

2.3

g/l

1.73

398

2775

(3029937) Albumin [Presence] in Urine by Test strip

747

5728

1.40

13.53

4.4

3.5

0.0

estimate

1.54

285

2020

(42529406) Shigella sp [Presence] in Stool by Culture

128

624

2.10

13.49

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

126

614

2.10

13.29

1.1

—

(3024731) MCV [Entitic volume]

2936

28271

2.14

13.27

24.0

17.1

90.8

90.6

1.70

2911

27873

(3035941) MCH [Entitic mass]

2936

28272

2.14

13.25

23.9

17.1

30.3

30.2

1.65

2911

27871

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

324

2108

1.60

13.20

1.8

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

136

684

2.03

13.18

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

2936

28278

2.13

13.15

24.1

17.1

4.5

e12/l

1.30

2887

27483

(3041096) Erythrocytes [Presence] in Urine by Automated

810

6322

1.38

13.14

3.7

2.9

—

(3007461) Platelets [#/volume] in Blood

2934

28253

2.11

13.12

24.1

17.2

259.7

256.3

e9/l

2.10

2893

27526

(36660697) Celiac disease serology panel - Serum

297

1898

1.63

13.02

1.3

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

484

3448

1.48

13.01

3.4

3.7

0.8

mmol/l

0.47

456

3231

(3000963) Hemoglobin [Mass/volume] in Blood

2936

28286

2.12

13.00

24.2

17.2

135.9

g/l

0.09

2911

27881

(3010813) Leukocytes [#/volume] in Blood

2936

28289

2.12

12.95

24.1

17.2

6.7

6.6

e9/l

0.70

2889

27487

(3002385) Erythrocyte distribution width [Ratio]

2288

20899

1.38

12.90

19.8

14.6

13.5

13.6

0.69

2256

20424

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

182

3.00

12.48

1.2

1.1

—

(3025941) Bacteria identified in Stool by Culture

218

1299

1.73

12.46

1.3

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

238

1456

1.69

12.36

2.3

2.1

7.9

7.6

ug/l

0.06

196

1286

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

105

491

2.18

12.33

1.2

45.9

39.5

u/ml

—

(3019150) Specific gravity of Urine by Refractometry

606

4549

1.41

12.25

4.4

3.4

1.0

kg/l

0.29

674

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

180

2.98

12.10

1.2

1.1

—

(4010399)

235

1441

1.68

12.10

1.5

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

319

2112

1.57

12.04

6.2

8.1

5.0

5.1

kpa

0.61

306

2022

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

101

470

2.19

12.01

1.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

357

2428

1.53

11.94

6.8

7.3

104.6

104.5

mmol/l

0.06

352

2371

(3027801) Oxygen [Partial pressure] in Arterial blood

318

2111

1.57

11.86

6.2

8.1

12.5

12.8

kpa

0.51

306

2020

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2665

25123

1.49

11.67

5.2

4.4

2.8

2.9

mmol/l

1.41

2483

23346

(40759836) Histone Ab [Presence] in Serum by Immunoblot

180

2.92

11.50

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

180

2.92

11.50

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

3.81

11.46

1.1

1.7

4.7

6.1

u/l

1.60

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

395

2769

1.49

11.42

2.5

23.2

23.6

0.20

335

2404

(3022217) INR in Platelet poor plasma by Coagulation assay

349

2385

1.52

11.40

27.4

21.7

1.3

inr

0.31

371

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

181

2.91

11.39

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

181

2.91

11.39

1.2

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

134

707

1.94

11.38

1.6

620.0

497.9

titre

—

(3003396) Base excess in Arterial blood by calculation

316

2121

1.55

11.21

6.3

8.1

0.7

1.1

mmol/l

1.11

242

1680

(3009508) Creatinine [Moles/volume] in Urine

838

6715

1.34

11.17

3.3

7.7

7.6

mmol/l

0.26

702

5699

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2630

24782

1.46

11.01

4.7

4.0

4.7

4.8

mmol/l

2.16

2474

23189

(3004616) Nuclear Ab [Presence] in Serum

271

2.51

10.99

1.6

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

212

1298

1.68

10.98

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

436

3141

1.45

10.95

2.2

2.1

29.7

29.6

0.13

420

3045

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

121

625

1.97

10.94

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2613

24621

1.44

10.66

4.7

4.0

1.5

mmol/l

3.76

2440

22920

(3016502) Oxygen saturation in Arterial blood

282

1871

1.56

10.53

6.6

8.7

96.5

96.0

0.83

274

1808

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

162

933

1.78

10.45

4.8

4.3

24.1

24.0

mmol/l

0.11

152

863

(3005719) IgG [Mass/volume] in Serum or Plasma

262

1715

1.58

10.37

2.9

2.7

10.5

10.6

g/l

0.16

239

1574

(3044941) Cell count panel - Synovial fluid

280

2.42

10.27

1.6

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

103

514

2.04

10.27

1.8

2.1

0.0

g/l

0.00

474

(3003458) Phosphate [Moles/volume] in Serum or Plasma

377

2677

1.47

10.18

5.4

6.4

1.0

mmol/l

0.46

345

2503

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2533

23781

1.39

10.16

4.2

3.6

1.3

mmol/l

2.12

2345

22025

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

259

2.46

10.02

1.2

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

465

2.08

9.99

1.2

—

18.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

124

668

1.89

9.93

1.1

7.4

5.4

u/ml

0.15

100

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

109

563

1.97

9.88

1.8

2.0

38.4

37.7

g/l

0.51

100

491

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

461

2.07

9.84

1.2

1.4

3.7

3.8

mmol/l

0.17

437

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

106

545

1.98

9.74

1.8

2.1

0.0

g/l

0.24

501

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

384

2.17

9.67

1.1

6.3

3.6

u/ml

0.32

203

(3025159) Blasts/100 leukocytes in Blood

247

1622

1.57

9.65

4.2

4.4

0.1

0.5

0.68

385

(3021440) Promyelocytes/100 leukocytes in Blood

259

1726

1.55

9.48

4.1

4.4

0.2

0.1

0.23

460

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

120

650

1.88

9.46

2.2

2.4

384.1

876.2

ug/l

0.75

111

610

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

100

510

1.99

9.42

1.9

2.1

0.0

g/l

0.00

473

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

121

659

1.87

9.39

1.8

2.1

9.7

10.3

g/l

1.06

107

566

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

770

6227

1.32

9.36

1.8

1.6

1.4

mmol/l

0.08

657

5254

(3013139) Helicobacter pylori Ag [Presence] in Stool

228

1482

1.58

9.31

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

232

1520

1.57

9.16

3.1

2.7

132.4

179.2

ng/l

1.96

205

1357

(3017181) Myelocytes/100 leukocytes in Blood

267

1807

1.52

9.11

4.2

4.3

1.1

0.9

0.15

493

(40768443) Skin Pathology biopsy report

160

959

1.71

9.00

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

113

611

1.88

8.98

2.2

2.1

10.9

11.6

mg/l

0.31

106

574

(40761535) Cells panel - Urine sediment

230

1511

1.56

8.97

4.0

3.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

248

1658

1.54

8.95

4.0

4.1

0.6

0.08

361

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

102

534

1.94

8.93

1.3

1.4

486.8

495.5

mg/l

0.09

512

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

120

663

1.84

8.92

1.9

2.2

3.0

3.1

g/l

0.38

102

532

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

465

2.01

8.90

1.3

1.6

381.6

1098.2

e6/l

0.78

376

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

125

701

1.82

8.85

1.9

2.1

3.5

3.8

g/l

2.11

101

518

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

466

2.00

8.85

1.2

1.5

13.8

21.4

e6/l

0.32

355

(3002032) Base excess in Venous blood by calculation

257

1736

1.52

8.84

5.1

3.9

1.6

1.8

mmol/l

0.29

217

1402

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

125

702

1.81

8.81

1.9

2.1

7.2

7.3

g/l

0.36

104

543

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

125

702

1.81

8.81

1.9

2.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

2505

23605

1.35

8.76

17.8

12.6

40.1

0.03

1931

18217

(3014111) Lactate [Moles/volume] in Serum or Plasma

247

1659

1.53

8.73

6.6

7.4

1.2

1.3

mmol/l

0.59

238

1599

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

179

1117

1.64

8.65

1.7

1.5

—

(3012516) Albumin [Mass/volume] in Urine

749

6091

1.30

8.64

3.3

379.9

329.6

mg/l

0.11

467

3806

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

111

606

1.86

8.58

1.9

2.2

0.5

1.0

g/l

1.24

529

(3027945) Reticulocytes/100 erythrocytes in Blood

298

2096

1.47

8.42

2.3

2.9

1.8

0.02

269

1874

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

244

2.36

8.36

1.2

1.3

—

nmol/l

—

(3024263) Appearance of Synovial fluid

3.25

8.34

1.2

1.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

257

1759

1.50

8.31

7.2

9.1

121.0

121.5

g/l

0.18

252

1694

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

117

3.01

8.30

2.9

2.6

631.5

1253.8

u/ml

1.44

117

(3021447) Carbon dioxide [Partial pressure] in Venous blood

255

1743

1.51

8.30

5.2

3.8

5.9

5.8

kpa

0.37

247

1683

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

197

2.51

8.23

1.6

1.7

56.7

58.6

0.10

135

(1002224) Polysomnography panel

183

1165

1.61

8.17

1.1

—

(3019060) Gas panel - Arterial blood

182

1161

1.60

8.06

4.2

5.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

360

2.08

7.98

1.4

1.8

0.7

0.8

g/l

0.60

277

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

338

2466

1.42

7.84

6.6

5.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

161

2.63

7.78

1.1

1.2

0.0

1.3

u/ml

0.98

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

161

1006

1.63

7.77

6.6

10.0

24.1

24.4

mmol/l

0.56

148

949

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

117

2.93

7.69

1.1

1.0

1.1

u/l

0.75

(3000991) Gas panel - Venous blood

234

1603

1.50

7.55

6.5

8.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

244

2.28

7.47

1.5

1.6

16.4

28.4

iu/ml

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

235

1618

1.49

7.40

3.0

3.4

4.4

4.5

pmol/l

0.59

207

1453

(3028026) IgM [Mass/volume] in Serum or Plasma

202

1350

1.53

7.33

1.7

1.8

1.2

1.5

g/l

1.80

183

1242

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

304

2207

1.42

7.25

3.5

4.5

233.0

245.1

u/l

0.99

287

2101

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

6.90

7.15

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

123

2.78

7.06

1.2

1.1

2.5

8.6

nmol/l

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

379

1.98

6.98

1.1

18.0

10.6

au/ml

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

213

1456

1.50

6.96

2.3

2.1

13.5

12.9

nmol/l

0.51

187

1332

(4094501)

110

640

1.75

6.96

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

207

1410

1.50

6.88

4.1

3.1

4.6

4.7

kpa

0.17

199

1358

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

565

4575

1.29

6.53

1.6

13449463.6

34802081.7

pmol/l

0.72

461

3882

(3020682) Albumin/Creatinine [Ratio] in Urine

765

6431

1.25

6.48

3.9

4.0

5.5

9.2

mg/mmol

2.96

469

4066

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

400

3096

1.34

6.42

2.2

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

381

2931

1.34

6.37

1.6

—

(44813793)

154

2.49

6.35

1.2

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

112

673

1.69

6.34

1.5

1.6

0.0

0.5

iu/ml

1.17

131

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

159

1047

1.55

6.21

2.4

2.3

—

(3044290) Cell count panel - Cerebral spinal fluid

456

1.82

6.08

1.2

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

163

1085

1.53

6.07

1.5

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

443

1.83

6.02

1.7

1.8

227.6

207.9

pmol/l

0.68

424

(3023520) Reticulocytes [#/volume] in Blood

212

1492

1.45

6.01

2.9

2.8

73.2

71.0

e9/l

0.34

163

1114

(3036071) Salmonella sp Ab [Titer] in Serum

2.99

5.95

1.2

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

118

2.64

5.89

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

240

1743

1.41

5.73

3.0

3.5

1.2

mmol/l

0.11

210

1511

(3019225) pH of Specimen

283

2115

1.37

5.70

3.7

4.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

337

1.92

5.64

1.2

—

(3017732) Neutrophils [#/volume] in Blood

225

1621

1.42

5.63

2.1

2.9

4.2

4.0

e9/l

0.34

186

1332

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

357

2770

1.33

5.63

2.1

1.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

166

1129

1.50

5.61

3.8

3.5

1.5

1.7

mmol/l

0.27

125

857

(3028707) Methadone [Presence] in Urine by Screen method

441

1.79

5.51

2.6

3.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

441

1.79

5.51

3.7

3.4

58.5

56.6

0.79

441

(3011288) Drugs identified in Urine by Screen method

115

723

1.61

5.51

2.7

2.9

—

(3006653) Thiamine [Moles/volume] in Blood

105

2.68

5.49

1.4

127.5

126.3

nmol/l

0.06

105

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

148

990

1.52

5.42

2.0

2.2

5274.1

5410.2

u/l

0.02

409

(1001926) Buprenorphine [Presence] in Urine by Screen method

128

829

1.57

5.42

2.7

2.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

136

2.44

5.37

1.5

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

136

2.44

5.37

1.5

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

161

2.31

5.35

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

137

904

1.54

5.34

1.6

1.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.35

5.29

1.7

—

(3045414) Leukocytes [Presence] in Urine

141

940

1.52

5.25

1.8

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

389

1.82

5.25

1.3

—

65.5

—

(3022621) pH of Urine by Test strip

193

1375

1.43

5.16

3.0

2.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

164

2.27

5.14

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

349

2741

1.31

5.05

1.7

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

128

2.44

5.04

1.4

1.6

5.9

9.2

ug/l

1.41

112

(3026389) Candida sp identified in Specimen by Organism specific culture

301

1.91

5.02

1.5

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

205

2.11

5.01

2.7

2.0

15.8

20.0

mg/l

0.45

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

366

1.82

5.00

2.1

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

585

1.64

4.97

1.9

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

170

1193

1.45

4.94

3.9

3.5

5.1

5.2

kpa

0.09

160

1110

(3009343) pH of Capillary blood

168

1178

1.45

4.90

3.9

3.5

7.4

0.09

147

(3024928) Oxygen saturation in Venous blood

413

1.76

4.89

5.5

3.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.78

4.87

2.1

1.8

141.3

127.3

umol/l

0.08

(4027681)

131

2.38

4.81

1.3

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

161

1125

1.46

4.79

7.1

8.0

24.7

24.5

mmol/l

0.47

154

1055

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

522

1.67

4.77

2.4

3.3

34.7

55.6

mg/l

0.64

423

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

417

1.74

4.74

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

417

1.74

4.74

1.2

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

275

2111

1.33

4.68

2.6

2.2

0.2

g/l

1.74

255

1987

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

605

5122

1.23

4.64

4.5

4.2

2.7

2.3

ug/l

0.31

545

4605

(3011985) Renin [Units/volume] in Plasma

281

1.90

4.64

1.4

1.5

38.4

53.2

mu/l

0.48

247

(3034860) Kappa light chains.free [Mass/volume] in Serum

522

1.65

4.53

2.4

3.3

31.0

61.7

mg/l

1.76

420

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

243

1844

1.35

4.48

1.2

137.9

152.4

iu/ml

0.19

702

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

388

3138

1.27

4.47

1.8

1.7

1.4

0.50

335

2819

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

236

1784

1.35

4.46

2.0

1.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

380

1.75

4.46

1.2

3.4

3.8

u/ml

0.17

168

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

285

2220

1.31

4.39

3.6

3.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

123

832

1.50

4.34

4.5

2.6

0.6

0.7

1.36

117

803

(3028300) Cannabinoids [Presence] in Urine

155

1098

1.43

4.32

2.8

2.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

310

1.82

4.32

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

640

1.57

4.30

2.2

2.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

157

1119

1.42

4.24

5.8

3.1

129.9

128.7

g/l

0.28

152

1086

(46235355) HIV 1 and 2 tests - Meaningful Use set

569

4833

1.22

4.20

1.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

189

1394

1.38

4.19

1.8

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

354

2856

1.27

4.17

1.4

—

(3003338) MCHC [Mass/volume]

2294

21906

1.19

4.16

20.6

14.7

332.8

332.5

g/l

0.96

2286

21734

(3006184) Hemoglobin [Mass/volume] in Capillary blood

420

1.68

4.11

2.4

2.1

133.9

130.9

g/l

0.45

309

(3027944) Amphetamines [Presence] in Urine

151

1076

1.42

4.09

2.7

2.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

168

2.10

4.07

1.3

1.4

50260.6

87059.8

e6/l

0.23

116

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

155

2.14

4.05

1.5

1.4

23.7

32.4

0.65

(3027008) Opiates [Presence] in Urine

153

1096

1.42

4.03

2.7

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

152

1089

1.42

4.00

2.8

2.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.03

3.96

1.6

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

526

1.59

3.95

1.1

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

402

1.68

3.95

2.9

2.4

17.2

16.5

0.67

194

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

131

2.23

3.92

1.1

—

(4062490)

212

1.95

3.91

1.2

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

104

697

1.51

3.87

1.8

1.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

213

1.94

3.86

1.2

1.5

0.5

0.4

g/l

0.31

151

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.29

3.86

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

235

1817

1.32

3.84

7.7

8.1

9.1

9.2

mmol/l

0.07

224

1738

(3027135) IgG subclass 1 [Mass/volume] in Serum

214

1.93

3.82

1.2

1.4

7.0

6.9

g/l

0.07

148

(3028192) IgG subclass 2 [Mass/volume] in Serum

214

1.93

3.82

1.2

1.4

3.3

2.9

g/l

0.46

152

(3014051) Protein [Presence] in Urine by Test strip

445

1.63

3.80

2.0

2.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

346

1.72

3.79

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.74

3.75

1.5

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

237

1.87

3.74

1.2

1.5

—

(3036489) Thrombin time

124

869

1.45

3.71

2.1

2.0

22.1

21.4

0.36

108

750

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

175

2.01

3.68

3.9

4.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

142

1023

1.41

3.65

8.8

11.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

268

1.80

3.65

1.1

1.3

236.1

293.7

pmol/l

1.06

203

(3016879) Cocaine [Presence] in Urine

139

999

1.41

3.63

2.9

2.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

183

1.98

3.63

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

157

2.05

3.55

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

184

1390

1.34

3.55

1.4

24.8

30.3

iu/l

1.88

162

1203

(3021879) Hepatitis B virus core Ab [Presence] in Serum

244

1920

1.29

3.52

1.4

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

115

804

1.45

3.50

1.2

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

172

1.99

3.48

1.4

1.2

—

61.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

538

4626

1.20

3.47

1.5

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

2.62

3.47

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

173

1.98

3.43

1.5

1.4

1.3

1.1

promille

0.34

131

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

529

1.55

3.43

1.1

0.9

1.2

u/ml

0.30

192

(3003888) Timothy IgE Ab [Units/volume] in Serum

476

1.57

3.36

1.1

4.2

5.6

u/ml

0.43

234

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

390

1.63

3.35

1.2

2.0

2.8

u/ml

0.47

139

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.73

3.34

1.5

1.6

2.9

2.4

mg/l

—

(3023410) Appearance of Cerebral spinal fluid

219

1.84

3.27

1.3

1.8

—

(3000330) Specific gravity of Urine by Test strip

136

993

1.39

3.27

3.6

3.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

149

2.02

3.25

2.3

2.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.17

3.21

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

325

1.67

3.21

1.1

1.5

g/l

0.28

294

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

623

1.47

3.12

3.4

2.9

0.3

u/ml

0.65

354

(40761536) Microorganisms panel - Urine sediment

246

1972

1.27

3.10

4.7

3.5

—

(3002256) Pathology report gross observation

375

3150

1.22

3.09

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

329

1.65

3.08

1.3

7.2

mmol/l

0.05

250

(3023511) Choriogonadotropin [Units/volume] in Urine

511

1.52

3.07

1.3

1.2

—

(3012501) Base excess in Blood by calculation

455

1.55

3.06

4.2

3.6

2.0

2.7

mmol/l

1.85

301

(3003181) Sodium [Moles/volume] in Urine

301

1.67

2.99

1.4

60.5

63.7

mmol/l

0.23

244

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

105

746

1.42

2.98

4.4

3.7

24.9

24.8

mmol/l

0.15

695

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

336

2803

1.22

2.97

4.8

4.1

32.5

32.2

0.15

238

1924

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

117

849

1.39

2.95

1.3

175.7

226.2

miu/ml

0.88

412

(3020891) Body temperature

100

706

1.43

2.94

3.8

4.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

212

1680

1.28

2.94

2.4

2.5

74.7

68.4

ml/min/173m2

1.57

621

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.38

2.89

1.3

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

214

1.79

2.88

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

314

1.63

2.82

2.0

1.8

1.5

1.6

mmol/l

0.53

306

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

238

1.73

2.81

1.1

1.2

69.9

62.7

u/l

0.17

157

(3010421) pH of Blood

539

1.48

2.79

4.0

3.7

7.4

0.02

447

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.23

2.77

1.3

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

166

1.88

2.76

1.3

1.1

—

(4198724)

104

2.12

2.74

2.3

2.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

256

1.69

2.71

1.7

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

454

1.51

2.68

1.1

0.9

1.5

u/ml

0.44

180

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

168

1.85

2.67

1.1

1.0

—

(3022313) Gas panel - Capillary blood

117

866

1.37

2.65

4.2

3.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

680

1.41

2.63

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

139

1058

1.33

2.62

1.7

1.6

3.6

3.9

mg/l

0.14

737

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

169

1.84

2.62

1.1

1.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

127

1.98

2.60

1.7

1.4

19.3

24.0

umol/l

0.50

121

(3001686) Cold agglutinin [Titer] in Serum or Plasma

2.90

2.58

1.2

1.9

—

215.7

—

(3042517) Benzodiazepines panel - Urine

4.01

2.56

3.6

3.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

149

1.89

2.56

1.7

1.6

4.3

6.0

u/l

0.48

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.46

2.54

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.43

2.54

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

101

2.09

2.52

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

157

1.86

2.52

3.8

2.1

—

(3021901) Oxygen saturation in Capillary blood

332

1.58

2.51

3.0

2.8

—

(3034770) Mitochondria Ab [Titer] in Serum

679

1.40

2.48

1.3

370.0

1087.1

titre

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.47

2.48

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.47

2.48

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

673

1.39

2.44

1.5

1.4

10.4

10.6

u/l

0.06

552

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

304

1.59

2.41

1.2

—

(3007463) Buprenorphine [Presence] in Urine

5.01

2.40

15.2

4.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

354

1.53

2.35

1.2

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

275

1.61

2.34

1.7

1.6

—

(3037121) Protein [Mass/volume] in Urine

721

1.37

2.34

2.8

3.5

0.3

g/l

0.29

310

(3047181) Lactate [Moles/volume] in Blood

586

1.41

2.32

6.1

7.6

1.2

1.3

mmol/l

0.85

504

(3002523) Influenza virus A Ag [Presence] in Specimen

479

1.45

2.29

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

208

1.69

2.26

1.1

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

216

1.67

2.25

1.1

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

481

1.44

2.25

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

2.16

2.24

5.4

2.2

10.0

9.4

0.05

(3042111) Morphology [Interpretation] in Bone marrow Narrative

327

1.54

2.22

1.5

1.8

—

(3002619) Bacteria identified in Specimen by Culture

2.78

2.20

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

210

1.67

2.19

1.3

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

467

1.44

2.19

2.8

3.2

24.3

25.1

mmol/l

0.95

400

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

353

1.51

2.17

1.4

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

395

1.48

2.14

2.0

3.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

123

951

1.31

2.14

1.6

258.4

310.0

mu/l

2.35

115

861

(3010726) Horse dander IgE Ab [Units/volume] in Serum

446

1.44

2.11

1.1

0.7

1.8

u/ml

1.24

104

(4146454)

205

1.67

2.11

2.9

—

(3032057) Clostridioides difficile [Presence] in Stool

2.71

2.10

1.3

2.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

131

1.84

2.08

1.3

1.2

—

354.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.91

2.07

1.2

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

111

851

1.32

2.06

1.6

1.8

1.6

g/l

0.20

734

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.03

2.05

1.3

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

154

1.76

2.04

1.1

1.0

ratio

—

(4306422)

384

1.47

2.01

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

351

3053

1.17

2.01

2.7

0.6

0.7

ug/l

1.20

209

1845

(3024869) Neuronal Ab [Presence] in Serum

2.82

2.00

1.0

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

443

1.43

1.99

2.8

3.0

35.6

38.2

umol/l

0.27

393

(44806071)

2.73

1.93

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.45

1.93

1.5

1.2

38.3

38.4

g/l

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

447

1.42

1.91

2.6

—

(3008295) Osmolality of Serum or Plasma

211

1.62

1.91

1.3

1.6

275.9

282.7

mosm/kgh2o

0.94

177

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

111

862

1.30

1.90

2.1

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

450

4008

1.14

1.88

1.6

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.40

1.85

1.2

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

101

778

1.31

1.84

2.0

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

455

4061

1.14

1.84

4.0

3.7

21.9

21.6

0.16

197

1770

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.50

1.83

1.0

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

683

1.33

1.83

1.3

80.7

230.4

titre

0.83

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.76

1.79

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.76

1.79

1.5

1.6

0.3

0.1

nmol/l

—

(1616796) Gas panel - Central venous blood

420

1.41

1.78

4.5

3.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

102

1.87

1.76

1.1

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

177

1.64

1.76

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

532

1.36

1.75

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

117

1.80

1.74

1.1

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

389

1.42

1.73

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.67

1.72

2.0

1.4

—

(3023419) Bacteria identified in Sputum by Culture

234

1.54

1.70

3.1

2.8

—

(3044927) Protein electrophoresis panel - Urine

171

1.64

1.70

1.1

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.06

1.70

1.1

1.4

92.5

88.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

133

1.73

1.69

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

349

1.44

1.69

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

105

1326

0.78

1.68

1.4

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

460

1.38

1.66

1.4

1.5

118.3

115.3

u/ml

0.08

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

134

1.72

1.66

2.9

2.2

—

(3051611) Lipemic interference index of Serum or Plasma

212

1.56

1.65

2.3

3.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

142

1.70

1.64

1.0

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

1.93

1.64

1.8

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

3.58

1.61

1.0

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

3.58

1.61

2.0

4.6

3.1

mg/l

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.07

1.59

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.07

1.59

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

214

1.55

1.59

1.9

4.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.00

1.59

1.1

89.9

90.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

136

1.70

1.58

1.1

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.70

1.58

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

321

1.44

1.57

2.8

3.5

0.9

1.4

0.87

255

(3004451) EKG impression Narrative

1.85

1.56

1.4

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

176

1.60

1.54

3.8

2.0

13.0

13.2

0.02

(3017354) Segmented neutrophils/100 leukocytes in Blood

184

1.58

1.54

2.0

3.4

66.1

56.3

1.33

125

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.93

1.54

2.9

2.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.28

1.53

2.2

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

418

1.37

1.49

1.2

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

162

1.61

1.49

1.3

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

524

0.68

1.49

4.9

3.3

22.8

25.6

mg/l

0.20

326

(3020874) Milk IgE Ab [Units/volume] in Serum

170

1.59

1.49

1.1

1.0

0.1

4.5

u/ml

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

2.00

1.48

1.0

1.2

—

29.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.00

1.48

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

1.48

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

309

1.43

1.47

1.8

2.3

6.9

6.7

umol/l

0.05

231

(40768795) Lymph node Pathology biopsy report

267

0.56

1.46

1.1

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.84

1.45

2.1

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.88

1.44

1.1

1.2

—

0.2

g/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

151

0.46

1.43

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.08

1.38

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.08

1.38

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.08

1.38

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.08

1.38

1.1

—

(3000285) Sodium [Moles/volume] in Blood

2.61

1.36

1.0

—

(3045424) Erythrocytes [Presence] in Urine

392

1.36

1.34

1.5

1.4

—

(3028433) Virus identified in Specimen by Culture

1.87

1.34

1.6

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

462

1.33

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

352

1.37

1.29

1.8

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

500

1.31

1.28

1.3

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.23

1.24

1.1

1.6

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

220

1.46

1.23

2.4

2.2

32.6

0.00

220

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

112

926

1.22

1.4

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

559

0.73

1.21

2.0

1.7

—

(4268621)

263

1.41

1.20

2.4

2.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

101

1.69

1.19

2.7

1.6

31.8

30.1

umol/l

0.22

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.11

1.18

1.3

1.7

51.1

125.5

ng/l

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

307

1.37

1.17

1.9

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.50

1.15

1.0

1.2

1.7

1.8

umol/24h

—

(3034426) Prothrombin time (PT)

1.73

1.15

1.1

—

(3011412) CD3 cells [#/volume] in Blood

224

1.43

1.14

3.6

2.6

1.4

1.2

e9/l

0.66

131

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

493

0.73

1.11

2.9

3.5

23.8

28.5

u/ml

0.28

476

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.78

1.10

4.0

4.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.78

1.10

1.1

1.2

—

(3017569) Oxygen content in Arterial blood

1.69

1.07

6.1

2.9

—

(21494890) Protein electrophoresis panel - 24 hour Urine

169

1.48

1.07

1.4

2.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

161

1.49

1.06

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

401

1.30

1.05

1.6

1.4

26.5

27.8

u/l

0.11

333

(3006462) Nitrate [Presence] in Urine

1.71

1.05

4.5

2.6

—

(44806420)

1.96

1.03

2.1

2.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.27

1.03

1.2

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.84

1.02

1.1

—

(4211845)

1.65

1.00

4.3

2.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.84

0.98

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

772

0.80

0.98

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.18

0.98

1.8

2.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

434

1.27

0.95

1.3

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

247

2225

1.12

0.95

3.5

4.4

36.5

18.5

ug/l

0.25

197

1765

(4015189)

1.89

0.94

6.9

1.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

260

1.35

0.93

4.7

5.3

178.3

62.9

u/ml

0.43

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

184

0.60

0.92

1.2

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

653

1.22

0.92

2.0

3.4

5.1

iu/l

1.87

251

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.73

0.92

1.1

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.73

0.92

1.1

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.73

0.92

1.1

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

619

0.79

0.90

1.3

1.5

—

(44790047)

245

1.35

0.89

1.7

1.6

—

(44790049)

245

1.35

0.89

1.7

1.6

—

(44806118)

245

1.35

0.89

1.7

1.6

—

(44790048)

245

1.35

0.89

1.7

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

471

0.76

0.87

1.3

1.5

—

(3037756) Immunofixation for Serum or Plasma

361

1.28

0.85

1.4

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.67

0.85

1.1

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

488

1.23

0.83

5.5

6.2

124.6

878.2

iu/ml

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

205

1.37

0.83

2.5

2.8

—

(3020491) Glucose [Moles/volume] in Blood

171

1.41

0.83

1.7

1.9

6.1

6.6

mmol/l

0.76

116

(4035726)

199

2210

0.89

0.82

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

197

1.37

0.82

1.1

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.88

0.81

1.2

2.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.61

0.81

1.0

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.70

0.80

1.0

1.2

115.0

98.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.70

0.80

1.0

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

173

1.39

0.78

2.7

2.6

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.78

0.0

7.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

331

1.27

0.77

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

191

1.36

0.77

1.9

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

521

1.21

0.76

1.9

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

604

0.81

0.76

1.4

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

244

1.31

0.75

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.64

0.75

2.3

2.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

459

1.22

0.75

2.3

2.1

0.9

0.8

nmol/l

0.42

387

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.09

0.74

1.4

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

360

1.25

0.74

1.0

1.1

2.1

3.9

u/ml

0.59

138

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

301

0.73

0.74

1.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.84

0.73

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.84

0.73

1.0

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.84

0.73

1.0

1.1

—

7.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

133

1.43

0.73

2.3

1.5

—

(3019977) pH of Arterial blood

108

1.48

0.73

9.0

3.4

7.4

—

(3003694) ABO and Rh group [Type] in Blood

734

7012

1.06

0.73

1.5

—

(3025130) Human papilloma virus identified in Specimen

398

1.23

0.72

1.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

291

1.27

0.71

1.9

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.92

0.70

1.4

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

1.92

0.70

1.4

1.0

—

(3011648) Oxygen content in Venous blood

169

1.36

0.69

13.4

2.2

10.7

11.0

0.18

169

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

118

1.44

0.69

1.7

2.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

446

1.21

0.68

1.6

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

1.56

0.68

5.0

12.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

865

0.85

0.68

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

102

1.47

0.67

1.5

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

102

1.47

0.67

1.5

1.9

—

(4024509)

205

1.32

0.67

1.1

1.6

—

(3005033) Fetal Nuchal fold Thickness US

583

0.82

0.67

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

357

1.24

0.66

4.0

5.6

360.8

380.8

umol/l

0.44

310

(3044242) Glucose [Moles/volume] in Arterial blood

103

1.46

0.65

9.1

2.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

260

1.27

0.64

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

260

1.27

0.64

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

172

1890

0.90

0.63

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

261

1.27

0.62

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

270

1.26

0.62

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.55

0.62

1.1

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

1.63

0.62

1.1

1.4

65.4

55.9

mu/l

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.67

0.61

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

587

0.83

0.61

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

462

1.19

0.61

1.5

1.7

—

(3035880) pH of Pleural fluid

1.48

0.60

1.5

1.3

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.60

0.0

8.5

—

71.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

105

1.43

0.60

1.0

1.1

1532.5

1398.3

miu/ml

0.13

105

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

148

1.35

0.59

1.4

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.45

0.59

1.1

264.1

212.0

iu/ml

0.23

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

418

1.20

0.58

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

112

0.62

0.58

2.3

2.4

77.1

150.8

nmol/l

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

273

1.25

0.58

2.0

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

712

0.85

0.57

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

158

1.33

0.57

1.3

2.0

—

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

161

0.68

0.57

1.9

1.8

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

711

0.86

0.57

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

711

0.86

0.57

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.51

0.56

2.5

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

439

1.19

0.56

1.4

0.3

0.4

nmol/l

0.79

342

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

258

2765

0.93

0.55

1.9

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

747

1.14

0.55

2.1

1.2

2.4

ug/l

1.07

681

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

709

0.86

0.55

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

1.58

0.54

2.3

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

267

1.24

0.54

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

222

1.26

0.53

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

227

0.75

0.53

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

405

1.19

0.53

1.1

20.4

1374.5

iu/ml

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

181

0.72

0.52

1.8

2.0

3.2

2.0

u/field

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

323

1.21

0.52

1.1

1.0

0.3

0.4

u/ml

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

490

1.17

0.51

2.4

2.5

63.7

90.1

ug/min

0.39

299

(3024522) Salmonella sp identified in Specimen by Organism specific culture

269

1.23

0.51

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

500

1.16

0.50

4.8

3.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.46

0.50

1.5

2.3

—

(3000012) Reticulocyte production index

101

1.39

0.49

1.9

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

399

1.18

0.49

1.0

1.1

3.3

2.4

u/ml

0.24

146

(3036782) Glucose [Moles/volume] in Pleural fluid

163

1.29

0.48

1.7

1.4

6.0

6.4

mmol/l

0.33

155

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

115

1042

1.11

0.48

1.3

1.4

—

(4034850)

719

1.13

0.48

11.5

7.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

128

1.33

0.47

1.0

946.8

666.1

ng/l

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.49

0.47

1.9

1.3

2.4

2.9

mmol/l

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

272

1.22

0.47

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

236

1.23

0.46

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

646

1.13

0.46

1.7

1.5

251.2

167.3

pmol/l

0.18

635

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.38

0.46

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

449

1.16

0.45

1.9

1.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

129

1.32

0.45

1.0

244.1

346.4

ng/l

0.83

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

147

1.29

0.45

1.2

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.40

0.44

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

432

1.16

0.44

1.8

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

507

1.15

0.44

1.9

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

130

1.31

0.44

1.0

18.3

49.1

ng/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.61

0.43

2.8

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

113

1.33

0.42

2.5

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

604

1.13

0.41

3.4

2.8

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.0

—

(3025315) Body weight

0.00

0.40

0.0

4.5

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.40

0.0

12.7

—

161.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

835

1.10

0.40

1.3

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

362

1.16

0.39

1.3

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.43

0.39

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.43

0.39

1.2

—

(3014271) Vancomycin [Susceptibility]

1.41

0.39

2.9

2.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

115

1.31

0.38

2.5

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

269

2554

1.06

0.38

1.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.39

0.38

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.32

0.37

1.7

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.32

0.37

3.0

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.32

0.37

6.0

6.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

188

1.23

0.37

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

188

1.23

0.37

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

188

1.23

0.37

1.4

1.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.35

0.37

1.0

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.35

0.37

1.4

3.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.35

0.37

2.0

3.6

—

11.7

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

290

1.17

0.36

1.6

1.9

—

1031.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

180

1.22

0.36

2.0

1.4

18543.2

67750.4

e6/l

0.83

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.66

0.35

1.4

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.64

0.35

1.8

3.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

245

1.19

0.35

1.7

—

(40768441) Liver Pathology biopsy report

199

1.21

0.35

1.3

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.30

0.33

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.30

0.33

1.3

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.35

0.32

1.4

1.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

165

0.79

0.32

1.2

1.3

—

(40768793) Breast Pathology biopsy report

656

1.10

0.31

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

221

1.18

0.30

1.9

1.5

28.5

32.1

g/l

0.82

204

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.29

0.30

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.25

0.29

1.1

1.4

—

(3012441) Differential panel - Pleural fluid

176

1.19

0.28

1.9

1.4

—

(3041354) Potassium [Moles/volume] in Venous blood

223

1.17

0.28

3.3

2.1

4.0

mmol/l

0.33

218

(3035285) Chloride [Moles/volume] in Venous blood

223

1.17

0.28

3.3

2.1

106.3

105.4

mmol/l

0.79

218

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

242

1.16

0.28

1.3

1.1

—

(4133840)

1.23

0.27

1.0

1.2

—

(3022689) Creatine [Moles/volume] in Urine

1.23

0.27

1.5

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

185

1762

1.05

0.27

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

113

1.24

0.26

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.26

0.26

2.8

2.6

—

(1761868) Lipid panel - Serum or Plasma

981

9976

0.98

0.26

2.7

2.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.23

0.25

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

1.20

0.25

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

159

0.82

0.24

1.3

1.5

—

(3042631) Mycobacterium sp identified in Specimen

255

1.14

0.24

3.3

2.6

—

(3047189) Immunofixation for 24 hour Urine

0.71

0.24

1.0

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

227

1.15

0.23

1.8

—

(21494434) Karyotype in Bone marrow

171

1.17

0.23

1.2

—

(3017704) Immunofixation for Urine

1.24

0.23

1.3

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

153

1.18

0.22

1.4

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

153

1.18

0.22

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.74

0.22

1.1

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

219

1.14

0.22

3.4

2.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.19

0.21

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

22.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.21

0.0

1.0

—

22.8

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

6.1

—

443.3

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.21

0.0

1.9

—

1.3

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.21

0.0

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

123

0.81

0.20

4.9

2.8

42.8

41.8

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.20

0.0

2.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.20

0.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

202

1.14

0.20

2.0

1.4

969.2

1528.5

e6/l

0.60

139

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.22

0.20

1.2

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

232

1.12

0.18

1.7

1.4

1.0

g/l

0.19

232

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.21

0.18

1.0

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

119

1.18

0.17

1.1

17.9

25.9

u/l

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

119

1.18

0.17

1.1

92.0

85.4

u/l

—

100

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

195

0.87

0.17

1.2

1.4

9.2

11.9

mmol/l

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.13

0.17

8.7

3.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.13

0.17

8.9

3.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.72

0.17

1.0

1.5

9.6

9.0

ug/l

—

(3045788) Cell count panel - Pleural fluid

167

1.14

0.16

2.0

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

173

0.87

0.16

1.7

1.6

8.2

7.6

mmol/l

—

110

(3039443) Prostate specific Ag panel - Serum or Plasma

398

1.08

0.16

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

936

1.05

0.15

1.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.10

0.15

1.1

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.10

0.15

1.4

1.6

—

(3033799) Differential panel - Peritoneal fluid

0.77

0.15

1.2

2.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

178

1.12

0.15

7.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

159

1.13

0.15

1.1

1.0

0.2

3.8

u/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

247

1.09

0.13

1.0

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

500

1.06

0.13

1.2

226.3

280.3

u/ml

1.00

305

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

117

0.85

0.13

2.2

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

161

1.12

0.13

2.3

1.6

—

(21494755) Public health laboratory ask at order entry panel

311

3170

0.98

0.12

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

297

1.08

0.12

1.3

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

375

1.07

0.12

1.9

1.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

105

1.14

0.11

2.0

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

342

0.93

0.10

1.2

1.4

2.9

3.8

ug/l

0.46

305

(3026250) Tacrolimus [Mass/volume] in Blood

115

0.87

0.10

43.8

34.6

7.3

7.4

ug/l

—

105

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.14

0.10

2.2

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

116

1.12

0.09

1.6

1.2

3.5

4.9

umol/l

0.61

111

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.11

0.09

1.3

2.2

14.0

18.6

umol/l

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.86

0.07

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

167

1.08

0.06

3.2

2.9

981.0

632.6

e6/l

—

(3024932) HLA-DR beta [Type]

0.86

0.06

1.0

1.1

—

(3024471) HLA-A [Type]

0.84

0.06

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.84

0.06

4.1

4.0

—

(40768446) Kidney Pathology biopsy report

101

0.89

0.06

1.6

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

109

1.10

0.06

2.0

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

119

1.09

0.06

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

119

1.09

0.06

1.7

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

119

1.09

0.06

1.7

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

119

1.09

0.06

1.7

1.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

769

0.97

0.05

4.1

4.0

296.8

688.1

u/ml

0.57

657

(3015183) Erythrocyte sedimentation rate

139

1.08

0.05

1.3

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

534

1.03

0.05

1.2

—

(40768800) Prostate Pathology biopsy report

273

0.95

0.05

1.1

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

161

1.06

0.03

1.0

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

161

1.06

0.03

2.6

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

102

1.08

0.03

1.4

1.9

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

112

1.07

0.03

2.8

1.5

—

783425.0

iu/ml

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

158

0.95

0.02

2.7

1.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

590

1.02

0.02

1.5

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

242

1.03

0.02

2.1

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

186

0.97

0.00

1.6

1.3

59.1

57.5

pmol/l

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

226

0.97

0.00

1.1

—

(3045142) Bone marrow Pathology biopsy report

254

1.02

0.00

1.3

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

314

1.02

0.00

2.6

2.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

385

1.01

0.00

2.4

2.6

13.1

0.00

379

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

142

0.99

0.00

2.7

2.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

328

1.01

0.00

3.3

3.2

0.8

nmol/l

0.06

252

(4281824)

287

1.01

0.00

1.2

—

(3051651) Icteric interference index of Serum or Plasma

147

1.02

0.00

2.3

3.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.94

0.00

3.8

3.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.94

0.00

1.7

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.94

0.00

2.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.0

1.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.86

0.00

1.4

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.2

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

3.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3042733) HLA Ab [Presence] in Serum

1.00

0.00

6.8

4.9

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.96

0.00

1.6

1.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.96

0.00

1.6

1.5

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

3.1

—

(3035933) Granulocytes/100 leukocytes in Blood

0.95

0.00

1.4

1.3

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

8.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

8.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

3.0

—

7.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.94

0.00

1.9

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.94

0.00

1.9

2.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.6

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

2.4

—

4.7

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

10.6

—

113.8

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

133.9

—

(3020650) Glucose [Presence] in Urine

0.87

0.00

1.5

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_ENTESOPATHYLOWNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_ENTESOPATHYLOWNAS	1.184 [1.06, 1.33]	0.004
Birth year	0.991 [0.98, 1.0]	0.035

During the follow-up period (1.1.1998 — 31.12.2019), 1019 out of 9037 females with M13_ENTESOPATHYLOWNAS died.

Males

Parameter	HR [95% CI]	p-value
M13_ENTESOPATHYLOWNAS	1.203 [1.06, 1.36]	0.003
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 689 out of 5860 males with M13_ENTESOPATHYLOWNAS died.

Mortality risk

Mortality risk for people of age

years, who have M13_ENTESOPATHYLOWNAS.

N-year risk	Females	Males
1	0.101%	0.218%
5	0.636%	1.265%
10	1.486%	3.29%
15	2.856%	6.41%
20	5.179%	10.96%

Relationships between endpoints

↥

Index endpoint: M13_ENTESOPATHYLOWNAS – Other/unspecified enthesopathies of lower limb, excluding foot

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other/unspecified enthesopathies of lower limb, excluding foot

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints